Table 1.
Probabilities, costs, and utilities used in the model.
Variable | Value | Range considered in sensitivity analysis | Reference |
---|---|---|---|
Sensitivity of cfDNA for microdeletion syndromes 22q11.2, PWA, 1p36 and Cri-du-chat. | 0.986 | 0.1–1 | [1,24] |
Specificity of cfDNA microdeletions | 0.991 | 0.1–1 | [1,24] |
Population prevalence of 22q11.2 | 0.000168 | 0.0001–0.001 | [19] |
Population prevalence of PWA | 0.0000378 | 0.00001–0.0001 | [21,23] |
Population prevalence of 1p36 | 0.0001 | 0.00001–0.001 | [22] |
Population prevalence of Cri-du-chat | 0.0000728 | 0.00001–0.0001 | [20] |
Probability of amniocentesis uptake | 0.7 | 0.1–1.0 | [27] |
Probability of amniocentesis-related loss | 0.006 | 0.001–0.01 | [28] |
Probability of abnormal US in 22q11.2 | 0.868 | 0.6–0.95 | [6] |
Probability of abnormal US in PWA | 0.273 | 0.1–0.5 | [7] |
Probability of abnormal US in 1p36 | 0.279 | 0.1 −0.5 | [25,26] |
Probability of abnormal US in Cri-du-chat | 0.482 | 0.2–0.7 | [9] |
Termination rate in 22q11.2 | 0.689 | 0.3–1.0 | [6] |
Termination rate in PWA | 0.812 | 0.3–1.0 | [29] |
Termination rate in 1p36 | 0.836 | 0.3–1.0 | [32] |
Termination rate in Cri-du-chat | 0.836 | 0.3–1.0 | [32] |
Probability of fetal loss in 22q11.2 | 0.361 | 0.1–0.5 | [31] |
Probability of fetal loss in PWA | 0.361 | 0.1–0.5 | [31] |
Probability of fetal loss in 1p36 | 0.64 | 0.5–0.85 | [31] |
Probability of fetal loss in Cri-du-chat | 0.64 | 0.5–0.85 | [31] |
Probability of normal fetal loss | 0.005 | 0.001–0.01 | [41] |
Probability of neonatal death in 22q11.2 | 0.164 | 0.01–0.3 | [6] |
Probability of neonatal death in PWA | 0.164 | 0.1–0.4 | [6] |
Probability of neonatal death in 1p36 | 0.7 | 0.5–0.9 | [30] |
Probability of neonatal death in Cri-du-chat | 0.7 | 0.3–0.9 | [30] |
Probability of neonatal death in normal fetus | 0.00218 | 0.001–0.005 | [42] |
Cost of cfDNA screen for aneuploidies | $1,726 | $0–10,000 | [33] |
Cost of cfDNA screen for aneuploidies with added microdeletions | $0 | $0–5,000 | See text |
Cost of genetic counseling | $95 | $50–150 | [27] |
Cost of 20-week ultrasound | $229 | $100–500 | [34] |
Cost of amniocentesis | $584 | $400–1,000 | [27,36] |
Cost of postnatal diagnosis | $282 | $100–700 | [36] |
Cost of termination or fetal loss | $3,165 | $2,500–4,000 | [27] |
Cost of neonatal death | $111,940 | $90,000–115,000 | [35] |
Cost of lifetime 22q11.2 | $1,249,429 | $900,000–1,500,000 | See text |
Cost of lifetime PWA | $1,252,029 | $900,000–1,500,000 | See text |
Cost of lifetime 1p36 | $1,252,029 | $900,000–1,500,000 | See text |
Cost of lifetime Cri-du-chat | $1,295,654 | $900,000–1,500,000 | See text |
Cost of first 2 years of DS | $89,799 | See text | |
Cost of lifetime DS | $1,072,352 | [27] | |
Utility of amniocentesis-related or spontaneous fetal loss during 2nd/3rd trimester | 0.93 | 0.9–0.95 | [38] |
Utility of pregnancy termination | 0.91 | 0.85–0.95 | [38] |
Utility of neonatal death | 0.76 | 0.7–0.8 | [39] |
Utility of neonate with 22q11.2 | 0.81 | 0.75–0.86 | [38] |
Utility of neonate with PWA | 0.81 | 0.75–0.86 | [38] |
Utility of neonate with 1p36 | 0.65 | 0.6–0.7 | [39] |
Utility of neonate with Cri-du-chat | 0.65 | 0.6–0.7 | [39] |
Utility of normal neonate | 1 | Assumed | [38] |
PWA: Prader–Willi and Angelman syndromes; US: ultrasound; DS: Down syndrome.